Abivax’s Record NASDAQ Stock Surge After Phase 3 Data
In biotech, Phase 3 data can change everything, or end everything. Few stories capture that...
Free Database of the Top 100 Public Biotechs in Europe
The FlotBio Map is live at map.flot.bio 🙌 Here’s a bit of background FlotBio Map...
Why AI in Biopharma Didn’t Live Up to the Hype
AI has reshaped entire industries, from software development to entertainment, yet its impact in healthcare...
Werner Lanthaler 🇦🇹 | Biopharma AI, CDMO, Antibody Optimization | E48
Why have early AI drug-discovery companies often overpromised but underdelivered? Biology is still complex and...
Thomas Lingelbach, Valneva | Vaccines, Lyme Disease | E47
Valneva now has three commercialized vaccines and a Lyme disease candidate in Phase 3. Philip...
Marc de Garidel, Abivax 🇫🇷 | Ulcerative Colitis, Inflammation | E46
When Abivax released stunning phase 3 results for ulcerative colitis, its 600% stock price surge...
Laurent Levy, Nanobiotix 🇫🇷 | Nanoparticles, Radiotherapy | E45
As Philip travels to France, Nanobiotix CEO Laurent Lévy discusses how the company broke into...
![Gerrit Sitters, LUMICKS 🇳🇱 | CAR-T therapy, Single-Cell Analysis | E44 [Sponsored]](https://flot.bio/wp-content/uploads/2025/10/Website-Thumbnail-Gerrit-Sitters-1080x648.avif)
Gerrit Sitters, LUMICKS 🇳🇱 | CAR-T therapy, Single-Cell Analysis | E44 [Sponsored]
As Philip tours Amsterdam, he visits the biotech tools startup LUMICKS. Founded in 2014, the...
Fabrice Chouraqui, Pharming 🇳🇱 | Transgenic Rabbits, Rare Diseases | E43
We travel to the offices of Pharming Group in Leiden, the Netherlands, to chat with...
![Daniela Marino, CUTISS 🇨🇭 | Tissue Engineering, Skin Grafts | E42 [Sponsored]](https://flot.bio/wp-content/uploads/2025/10/Website-Thumbnail-Daniela-Marino-1080x648.avif)
Daniela Marino, CUTISS 🇨🇭 | Tissue Engineering, Skin Grafts | E42 [Sponsored]
Hot on the heels of CUTISS’ $60M Series C round, we catch up once more...
